| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| EBITDA | 345 | 74.7 | +362.3% |
| Profit before tax | 352 | 77.7 | +352.7% |
| Net profit | 265 | 54.9 | +382.3% |
| EPS | ₹4.50 | ₹0.92 | +389.1% |
L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 30,539 | — | — | |
| 338 | — | — | |
| 470 | 470 | 470 | |
| 30,671 | — | — | |
| 1,401 | 747 | 855 | |
| 1,401 | 747 | 855 | |
| 1,054 | 557 | 646 | |
| ₹17.92 | ₹9.47 | ₹10.98 | |
| — | −13.8% | — | |
| — | 1,873 | 1,379 | |
| — | −78.1 | −82.7 | |
| 1,795 | 1,795 | 1,296 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 30,539.2 | |
| - Cash, Equiv & ST Investments | — | — | 338.4 | |
| + Total Debt | 470.0 | 470.0 | 470.0 | |
| Enterprise Value | — | — | 30,670.8 | |
| EBITDA | 854.8 | 747.4 | 1,400.7 | |
| EBIT | 854.8 | 747.4 | 1,400.7 | |
| Net Income | 645.9 | 557.0 | 1,054.1 | |
| EPS, Adj (current shares) | 10.98 | 9.47 | 17.92 | |
| Growth %, YoY | — | -13.8 | — | |
| Cash from Operations | 1,378.6 | 1,873.5 | — | |
| Capital Expenditures | -82.7 | -78.1 | — | |
| Free Cash Flow | 1,295.9 | 1,795.3 | 1,795.3 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Star Health and Allied Insurance (NSE: STARHEALTH) had a market capitalisation of ₹31,330 crore at the 29 October 2026 close (₹532.40 a share), a PE ratio of 29.7 on the last four quarters' profit and a price-to-book ratio of 4.13. In FY26 its consolidated net profit was ₹557 crore; in Q2 FY27 (July–September 2026) it was ₹265 crore, up 382.3% year on year. Promoters held 58.00% of the shares on 30 September 2026.
Star Health and Allied Insurance's PE ratio is 29.7 at the 29 October 2026 close (₹532.40 a share): a market capitalisation of ₹31,330 crore divided by consolidated net profit of ₹1,054 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹557 crore) it is 56.3.
Star Health and Allied Insurance's price-to-book (PB) ratio is 4.13 at the 29 October 2026 close: a market capitalisation of ₹31,330 crore divided by shareholders' equity (book value) of ₹7,589 crore on 31 March 2026. That is a book value of ₹128.97 per share against a share price of ₹532.40.
Star Health and Allied Insurance's net worth — shareholders' equity in its consolidated balance sheet — was ₹7,589 crore on 31 March 2026, up 8.1% from ₹7,024 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹31,330 crore at the 29 October 2026 close.
Star Health and Allied Insurance's market capitalisation was ₹31,330 crore at the 29 October 2026 close: 58.85 crore shares at ₹532.40 each.
Star Health and Allied Insurance's debt-to-equity ratio was 0.06 on 31 March 2026: borrowings of ₹470 crore against total equity of ₹7,589 crore. A year earlier, on 31 March 2025, it was 0.07.
In FY26 (April 2025–March 2026), Star Health and Allied Insurance's consolidated net profit was ₹557 crore, down 13.8% from ₹646 crore in FY25.
In FY26, Star Health and Allied Insurance's return on equity (ROE) was 7.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year).
Star Health and Allied Insurance's basic earnings per share (EPS) were ₹9.47 in FY26, against ₹11.01 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹17.91.
Star Health and Allied Insurance's latest results are for Q2 FY27 (July–September 2026), filed on 27 October 2026: consolidated net profit ₹265 crore, up 382.3% from ₹54.9 crore in Q2 FY26.
Star Health and Allied Insurance's book value per share was ₹128.97 on 31 March 2026: shareholders' equity of ₹7,589 crore divided by the 58.85 crore shares in issue. The share price at the 29 October 2026 close was ₹532.40.
Promoters held 58.00% of Star Health and Allied Insurance on 30 September 2026, down 0.01 percentage points from 58.01% the previous quarter and down 0.02 percentage points from 58.02% a year earlier, according to the shareholding pattern filed with NSE.
Star Health and Allied Insurance has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
On 30 September 2026, Star Health and Allied Insurance's shares were held by promoters 58.00%, foreign portfolio investors (FII/FPI) 15.85%, domestic institutions (DII) 18.77% (including mutual funds at 10.43%) and retail and other non-institutional investors 7.37%. Over the year, FII holding was up 2.35 percentage points from 13.50% and DII holding was down 2.32 percentage points from 21.09%.
On FY26 consolidated figures, against Niva Bupa Health Insurance, ICICI Lombard and UCO Bank: Star Health and Allied Insurance's return on equity of 7.6% is the third highest of the four (Niva Bupa Health Insurance 3.5%, ICICI Lombard 17.8%, UCO Bank 8.6%; peer average 10.0%).
In FY26, Star Health and Allied Insurance earned net profit of ₹557 crore, against ₹131 crore for Niva Bupa Health Insurance. At the 29 October 2026 close, Star Health and Allied Insurance's market capitalisation was ₹31,330 crore against ₹13,440 crore for Niva Bupa Health Insurance, and its PE ratio on FY26 profit 56.3 against 102.8.
At the 29 October 2026 closing prices, on FY26 net profit, Star Health and Allied Insurance's PE ratio is 56.3, the second highest of the four: Niva Bupa Health Insurance 102.8, ICICI Lombard 28.3 and UCO Bank 10.0, a peer average of 47.0. Each is the company's market capitalisation at that price divided by its FY26 net profit.
From Star Health and Allied Insurance's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.